In the wake of the worsening coronavirus pandemic, Lupus Suppressant hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a result, the demand for Lupus Suppressant hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons. Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections. In 2020, from January to April, India has exported hydroxychloroquine API (active pharmaceutical ingredient) worth US$ 1.2 Bn. Attributed to above-mentioned facts global Lupus Suppressant hydroxychloroquine market is estimated to experience a year on year growth of over 100% by the end of 2020.
For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4769
Key Takeaways of Hydroxychloroquine Market Study
- Due to skyrocketing demand for hydroxychloroquine, the global hydroxychloroquine market is expected to create a value opportunity of around US$ 2.3 Bn by the end of 2020.
- The coronavirus pandemic has spiked the prices of API (active pharmaceutical ingredients) which is set to increase the market value by 2X through 2020.
- Based on drug type, anti-rheumatic drug has dominated the consumption of hydroxychloroquine in 2018 and is poised to account for nearly half of the market share by 2030.
- Due to the high prevalence of rheumatoid arthritis and systemic lupus erythematosus, United Stated is projected to remain a highly lucrative region during the forecast period.
- In terms of production, currently, India accounted for nearly half of the global production in 2019.
Key Segments Covered in the Hydroxychloroquine Industry Survey
- Hydroxychloroquine by Drug Type
- Anti-malarial Hydroxychloroquine Drug
- Anti-rheumatic Hydroxychloroquine Drug
- Lupus Suppressant Hydroxychloroquine Drug
- Anti-COVID 19 Hydroxychloroquine Drug
- Other Hydroxychloroquine Drugs
- Hydroxychloroquine by Region
- North America Hydroxychloroquine Market
- Latin America Hydroxychloroquine Market
- Europe Hydroxychloroquine Market
- Asia Pacific Hydroxychloroquine Market
- Middle East & Africa Hydroxychloroquine Market
Key Companies Profiled
- Abcam Plc.
- Advanz Pharma Group
- Amneal Pharmaceuticals Inc.
- Bayer AG
- Dr. Reddy’s Laboratories
- Ipca Laboratories
- Laurus Labs
- Mylan N.V (Viatris)
- Novartis AG (Sandoz)
- Prasco Laboratories
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wallace Pharmaceuticals Ltd.
- Zydus Cadila